Eradication of Residual Disease by Preemptive Immunointervention After Allogeneic Hematopoietic Stem Cells Transplantation in Chronic Lymphocytic Leukemia
Clinical trial NCT01849939 · UNKNOWN
Trial details
- NCT number
- NCT01849939
- Sponsor
- University Hospital, Clermont-Ferrand
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2017-09-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.